Inventor · disambiguated record
Arnaud Grandeury
Also filed as: GRANDEURY ARNAUD
14 granted patents·9 pending applications·22 citations·filing 2011–2024
88Inventor score
Top patents by PatentIndex Score
23 records- 0194US12064434B2Ribociclib tabletNOVARTIS AG·Filed 2022·Granted Aug 20, 2024·4 cites·6 claims
- 0294US10799506B2Ribociclib tabletNOVARTIS AG·Filed 2016·Granted Oct 13, 2020·11 cites·14 claims
- 0392US12419894B2Ribociclib tabletNOVARTIS AG·Filed 2024·Granted Sep 23, 2025·1 cites·4 claims
- 0492US11407735B2Crystalline forms of N-[4-(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamideNOVARTIS AG·Filed 2020·Granted Aug 9, 2022·4 cites·10 claims
- 0583US2025090531A1Ribociclib TabletNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0673US2025281492A1New crystalline forms of salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine -6-carboxylic acid dimethylamideNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0771US12252478B2Crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamideNOVARTIS AG·Filed 2022·Granted Mar 18, 2025·0 cites·23 claims
- 0871US12252479B2Crystalline forms OF N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamideNOVARTIS AG·Filed 2022·Granted Mar 18, 2025·0 cites·12 claims
- 0971US8933108B2Benzothiazolone compoundCAO JUN·Filed 2012·Granted Jan 13, 2015·1 cites·5 claims
- 1068US2020390771A1Ribociclib TabletNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1167US2023355582A1Modified release formulationNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1265US10251868B2Benzothiazolone compoundNOVARTIS AG·Filed 2018·Granted Apr 9, 2019·0 cites·22 claims
- 1365US9623012B2Formulation comprising benzothiazolone compoundNOVARTIS AG·Filed 2014·Granted Apr 18, 2017·1 cites·13 claims
- 1463US2015094346A1Benzothiazolone compoundCAO JUN·Filed 2014·Application pending·0 cites
- 1561US9913828B2Benzothiazolone compoundNOVARTIS AG·Filed 2016·Granted Mar 13, 2018·0 cites·9 claims
- 1660US12390468B2Crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamideNOVARTIS AG·Filed 2020·Granted Aug 19, 2025·0 cites·1 claims
- 1754US2021069150A1Modified release formulationNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1854US2016075670A1Benzothiazolone compoundCAO JUN·Filed 2015·Application pending·0 cites
- 1953US2015336914A1Benzothiazolone compoundCAO JUN·Filed 2015·Application pending·0 cites
- 2051US8884014B2Method for purifying a fused pyrrolocarbazole derivativeCEPHALON INC·Filed 2012·Granted Nov 11, 2014·0 cites·7 claims
- 2148US10934273B2Crystalline forms of 4-(2-((1R,2R)-2-hydroxycyclohexylamino)benzothiazol-6-yloxy)-N-methylpicolinamideNOVARTIS AG·Filed 2017·Granted Mar 2, 2021·0 cites·14 claims
- 2240US2016128979A1Modified release formulationGALLI BRUNO·Filed 2014·Application pending·0 cites
- 2322US8987448B2Preparation of anhydrous and hydrated polymorphs 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-YL)-1H-benzimidazol-2-YL]-1H-quinolin-2-one-lactic acid saltGRANDEURY ARNAUD·Filed 2011·Granted Mar 24, 2015·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Arnaud Grandeury files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →